BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12214584)

  • 1. Rituximab-induced serum sickness.
    Herishanu Y
    Am J Hematol; 2002 Aug; 70(4):329. PubMed ID: 12214584
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab-induced serum sickness.
    Schutgens RE
    Br J Haematol; 2006 Oct; 135(2):147. PubMed ID: 16869826
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum sickness following treatment with rituximab.
    Todd DJ; Helfgott SM
    J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
    Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
    Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab).
    D'Arcy CA; Mannik M
    Arthritis Rheum; 2001 Jul; 44(7):1717-8. PubMed ID: 11465726
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia.
    Catuogno M; Rezai S; Priori R; Magrini L; Valesini G
    Rheumatology (Oxford); 2005 Mar; 44(3):406. PubMed ID: 15637037
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment.
    Hellerstedt B; Ahmed A
    Ann Oncol; 2003 Dec; 14(12):1792. PubMed ID: 14630688
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura.
    Le Guenno G; Ruivard M; Charra L; Philippe P
    Intern Med J; 2011 Feb; 41(2):202-5. PubMed ID: 22747556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sickness following a first rituximab infusion with no recurrence after the second one.
    Mehsen N; Yvon CM; Richez C; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(5):967. PubMed ID: 19032839
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe serum sickness-like syndrome after omalizumab therapy for asthma.
    Pilette C; Coppens N; Houssiau FA; Rodenstein DO
    J Allergy Clin Immunol; 2007 Oct; 120(4):972-3. PubMed ID: 17716723
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia.
    Finger E; Scheinberg M
    J Clin Rheumatol; 2007 Apr; 13(2):94-5. PubMed ID: 17414540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
    Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
    J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab-induced serum sickness in overlapping syndrome between sjögren syndrome and systemic lupus erythematosus.
    Ungprasert P; Srivali N; Kittanamongkolchai W; Leeaphorn N; Griger DT
    J Clin Rheumatol; 2013 Sep; 19(6):360. PubMed ID: 23965477
    [No Abstract]   [Full Text] [Related]  

  • 15. Intra-CSF rituximab for lymhomatous meningitis.
    Chamberlain MC; Glantz MJ
    J Clin Oncol; 2007 Oct; 25(28):4508-9; author reply 4509-11. PubMed ID: 17906219
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
    Tuccori M; Focosi D; Blandizzi C; Del Tacca M; Petrini M
    J Natl Cancer Inst; 2009 Sep; 101(18):1288-9; author reply 1289-90. PubMed ID: 19687414
    [No Abstract]   [Full Text] [Related]  

  • 17. Desensitization protocol for rituximab-induced serum sickness.
    Fajt ML; Petrov AA
    Curr Drug Saf; 2014; 9(3):240-2. PubMed ID: 24861993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute pulmonary edema complicating rituximab infusion.
    Chan KH; Ng MK
    Eur J Intern Med; 2009 Jan; 20(1):e13. PubMed ID: 19237066
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA; McGratten M
    J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
    [No Abstract]   [Full Text] [Related]  

  • 20. [Repeated rituximab-induced serum sickness with anaphylaxis].
    Isoda A; Ishikawa T; Sato N; Miyazawa Y; Matsumoto M; Sawamura M
    Rinsho Ketsueki; 2016 Jun; 57(6):771-3. PubMed ID: 27384859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.